161 related articles for article (PubMed ID: 10821716)
1. Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
Inagaki M; Tsuri T; Jyoyama H; Ono T; Yamada K; Kobayashi M; Hori Y; Arimura A; Yasui K; Ohno K; Kakudo S; Koizumi K; Suzuki R; Kawai S; Kato M; Matsumoto S
J Med Chem; 2000 May; 43(10):2040-8. PubMed ID: 10821716
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the new antiarthritic drug candidate S-2474].
Inagaki M
Yakugaku Zasshi; 2003 May; 123(5):323-30. PubMed ID: 12772588
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibitors of cyclooxygenase-2 (COX-2).
Talley JJ
Prog Med Chem; 1999; 36():201-34. PubMed ID: 10818674
[No Abstract] [Full Text] [Related]
6. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.
Almansa C; Alfón J; de Arriba AF; Cavalcanti FL; Escamilla I; Gómez LA; Miralles A; Soliva R; Bartrolí J; Carceller E; Merlos M; García-Rafanell J
J Med Chem; 2003 Jul; 46(16):3463-75. PubMed ID: 12877584
[TBL] [Abstract][Full Text] [Related]
8. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
[TBL] [Abstract][Full Text] [Related]
9. 1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.
Khanna IK; Weier RM; Yu Y; Xu XD; Koszyk FJ; Collins PW; Koboldt CM; Veenhuizen AW; Perkins WE; Casler JJ; Masferrer JL; Zhang YY; Gregory SA; Seibert K; Isakson PC
J Med Chem; 1997 May; 40(11):1634-47. PubMed ID: 9171873
[TBL] [Abstract][Full Text] [Related]
10. COX-2-Selective NSAIDs: new and improved?
Lichtenstein DR; Wolfe MM
JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
[No Abstract] [Full Text] [Related]
11. Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor.
Barbey S; Goossens L; Taverne T; Cornet J; Choesmel V; Rouaud C; Gimeno G; Yannic-Arnoult S; Michaux C; Charlier C; Houssin R; Hénichart JP
Bioorg Med Chem Lett; 2002 Mar; 12(5):779-82. PubMed ID: 11859001
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2.
Esser R; Berry C; Du Z; Dawson J; Fox A; Fujimoto RA; Haston W; Kimble EF; Koehler J; Peppard J; Quadros E; Quintavalla J; Toscano K; Urban L; van Duzer J; Zhang X; Zhou S; Marshall PJ
Br J Pharmacol; 2005 Feb; 144(4):538-50. PubMed ID: 15655513
[TBL] [Abstract][Full Text] [Related]
13. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
14. Anti arthritic drugs--SMi conference: dual inhibitors. 28-29 April 2003, London, UK.
Evans R
IDrugs; 2003 Jun; 6(6):552-4. PubMed ID: 12861983
[No Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity.
Unangst PC; Connor DT; Cetenko WA; Sorenson RJ; Kostlan CR; Sircar JC; Wright CD; Schrier DJ; Dyer RD
J Med Chem; 1994 Jan; 37(2):322-8. PubMed ID: 8295221
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-inflammatory activity of chalcone derivatives.
Herencia F; Ferrándiz ML; Ubeda A; Domínguez JN; Charris JE; Lobo GM; Alcaraz MJ
Bioorg Med Chem Lett; 1998 May; 8(10):1169-74. PubMed ID: 9871729
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects.
Ochi T; Goto T
J Pharm Pharmacol; 2000 May; 52(5):553-60. PubMed ID: 10864144
[TBL] [Abstract][Full Text] [Related]
19. Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats.
Turull A; Queralt J
Immunopharmacology; 2000 Jan; 46(1):71-7. PubMed ID: 10665781
[TBL] [Abstract][Full Text] [Related]
20. 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2.
Talley JJ; Brown DL; Carter JS; Graneto MJ; Koboldt CM; Masferrer JL; Perkins WE; Rogers RS; Shaffer AF; Zhang YY; Zweifel BS; Seibert K
J Med Chem; 2000 Mar; 43(5):775-7. PubMed ID: 10715145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
